Jazz Pharmaceuticals plc (JAZZ) stock
JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$240.71+0.94 (+0.39%)
Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –
Jazz Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Jazz Pharmaceuticals's price to book ratio was 3.3× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 1.6× to 3.6×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | +0.7 |
| 2025 | Dec 31, 2025 | 2.6× | +0.7 |
| 2024 | Dec 31, 2024 | 2.0× | −0.5 |
| 2023 | Dec 29, 2023 | 2.5× | −1.2 |
| 2022 | Dec 30, 2022 | 3.6× | +1.7 |
| 2021 | Dec 31, 2021 | 1.9× | −0.8 |
| 2020 | Dec 31, 2020 | 2.8× | −0.1 |
| 2019 | Dec 31, 2019 | 2.9× | +0.3 |
| 2018 | Dec 31, 2018 | 2.5× | −0.8 |
| 2017 | Dec 29, 2017 | 3.3× | −0.4 |
| 2016 | Dec 30, 2016 | 3.7× | −2.2 |
| 2015 | Dec 31, 2015 | 5.9× | −1.6 |
| 2014 | Dec 31, 2014 | 7.5× | +1.2 |
| 2013 | Dec 31, 2013 | 6.3× | +2.8 |
| 2012 | Dec 31, 2012 | 3.4× | −9.1 |
| 2011 | Dec 30, 2011 | 12.5× | – |
See a number that looks wrong?